IGC Reports Financial Results for Fiscal Year Ended March 31 2020 - IGC Pharma, INC.

Press

Releases

July 13, 2020

IGC Reports Financial Results for Fiscal Year Ended March 31 2020

Related Posts

IGC Pharma Advances IGC-AD1 as a Potential Alzheimer’s Therapy Addressing Cognitive Impairment and Underlying Disease Pathology

December 2, 2024

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer’s Treatment

November 25, 2024

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in its Alzheimer’s Pipeline

November 14, 2024

CEO Update

Recap of AAIC24 Conference Participation and Poster Presentations

August 28, 2024

Desk of CEO Marijuana Reclass

July 25, 2024